2016年5月19日星期四

532-nm Diode Laser for the Treatment of Facial Telangiectasia and Pigmented Lesions

532-nm diode lasers are lightweight, extremely portable systems that are effective in the treatment of facial telangiectasia and various pigmented lesions. When compared to other popular modalities and laser wavelengths, the 532-nm diode laser can successfully treat facial telangiectasia and some pigmented facial lesions with less chance of collateral tissue damage and resultant complications.
The 532-nm diode laser is representative of technological innovations that enable small, lightweight, and affordable lasers to be used by the office-based cosmetic surgeon. Distinct advantages are evident when it is compared with other wavelength lasers. Because of the smaller spot size and depth of penetration, this laser also has treatment limitations; however, it provides a welcomed addition to the armamentarium for the surgeon treating facial ectatic and pigmented lesions.
Conclusion: Because of its demonstrated clinical effectiveness, ease of use, and lack of resultant purpura, as well as affordability and portability, this laser is well suited for the office-based cosmetic practice.
...
donna@gigaalaser.com

980nm 30w Lipolysis Laser



donna@gigaalaser.com

2016年5月12日星期四

532nm/980nm/810nm/940nm/1470nm Veins Removal Laser











VELAS Medical Diode Laser

Why choose the VELASE Medical diode laser?
The VELAS Medical Diode Laser is the multi-function diode laser, it can be used for EVLA, Veins Removal, Lipolysis, PLDD, ENT, Gynecology, Physical Therapy and Veterianry etc.
The VELAS is the Sino-German cooperation design and development, the core parts are from Germany. And it has CE, ISO and FDA etc certificates, it has very good quality and affordable price.
The VELAS has be sold in the market since 2005. It quality and performance are have been tested and approved by the market.
.......
donna@gigaalaser.com








1470nm EVLA Laser





donna@gigaalaser.com

532nm/940nm/810nm Dermatology Fractional Laser




donna@gigaalaser.com

2016年4月27日星期三

Diode laser cyclophotocoagulation in treatment of refractory glaucoma

AIM: To evaluate the long-term efficiency of diode laser transscleral cyclophotocoagulation (DL Tscpc) for refractory glaucoma.
METHODS: Retrospective analysis was made in 431 eyes with refractory glaucoma treated by DL Tscpc with lower energy power (1.5-2.5W) and more laser spots (26-34). Intraocular pressure (IOP), visualacuity, ocular symptoms and complications were observed after DLTscpc. Patients were followed up over 36 months.
RESULTS: Mean pre-operative IOP was (56.2±12.7)mmHg which was significantly different from the final follow-up mean IOP (17.3±8.8)mmHg. (P < 0.05). The success rate was 94.4% (68/72). Postoperative visual acuity kept no change in 399 eyes; elevated in 30 eyes and decreased in two eyes. The pain sense disappeared or remarkably relieved. The main complications included mild uveitis and hyphemae. Atrophy of eyeball occurred in two eyes.
CONCLUSION: It is concluded that DL TScpc is a simple, safe and effective therapy for eyes with refractory glaucoma through long-term observation.
KEYWORDS: diode laser; cyclophotocoagulation; refractory glaucoma